Unknown

Dataset Information

0

Successful Bridge-to-Recovery Treatment in a Young Patient with Fulminant Eosinophilic Myocarditis: Roles of a Percutaneous Ventricular Assist Device and Endomyocardial Biopsy.


ABSTRACT: Eosinophilic myocarditis (EM) is a rare condition characterized by myocardial eosinophilic infiltration due to various underlying etiologies. The patient with EM may benefit from appropriate use of mechanical circulatory support (MCS) that acts as a bridge to myocardial recovery in response to effective immunosuppressive therapy. A 16-year-old boy presented with cardiogenic shock due to fulminant myocarditis, for which a percutaneous ventricular assist device (PVAD) was immediately inserted. Based on the histological diagnosis of EM, immunosuppressive therapy was immediately commenced, leading to improvement of left-ventricular ejection fraction (27% to 47%). The PVAD was successfully removed on day 7. Cardiac magnetic resonance imaging and dual-tracer myocardial scintigraphy suggested limited extent of irreversible myocardial damage. For fulminant EM, the short-term use of PVAD, together with immunosuppressive therapy guided by an immediate histological investigation, may be an effective bridging strategy to myocardial recovery.

SUBMITTER: Hasegawa-Tamba S 

PROVIDER: S-EPMC6633872 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Successful Bridge-to-Recovery Treatment in a Young Patient with Fulminant Eosinophilic Myocarditis: Roles of a Percutaneous Ventricular Assist Device and Endomyocardial Biopsy.

Hasegawa-Tamba Saki S   Sugi Keiki K   Gatate Yodo Y   Sugiyama Kanako K   Muramatsu Toshihiro T   Nishimura Shigeyuki S   Yasuda Masanori M   Fukushima Kenji K   Nakano Shintaro S  

Case reports in emergency medicine 20190702


Eosinophilic myocarditis (EM) is a rare condition characterized by myocardial eosinophilic infiltration due to various underlying etiologies. The patient with EM may benefit from appropriate use of mechanical circulatory support (MCS) that acts as a bridge to myocardial recovery in response to effective immunosuppressive therapy. A 16-year-old boy presented with cardiogenic shock due to fulminant myocarditis, for which a percutaneous ventricular assist device (PVAD) was immediately inserted. Bas  ...[more]

Similar Datasets

| S-EPMC10057820 | biostudies-literature
| S-EPMC9214811 | biostudies-literature
| S-EPMC5695162 | biostudies-other
| S-EPMC5908263 | biostudies-literature
| S-EPMC7891289 | biostudies-literature
| S-EPMC9943699 | biostudies-literature
| S-EPMC8239812 | biostudies-literature
| S-EPMC4265228 | biostudies-literature
| S-EPMC8859629 | biostudies-literature
| S-EPMC8842092 | biostudies-literature